Price:
Rs. 65,000.00
Sample Type: EDTA BLOOD
Fasting Not Required
Notes: C8620
Frequently Asked Questions (FAQ's):
What does the Clinical Exome – Higher Depth (250X) test include?
This test analyzes all clinically relevant genes at high sequencing depth to detect pathogenic, likely pathogenic, and actionable variants.
How does Metropolis Healthcare perform this test?
Metropolis Healthcare uses next-generation sequencing (NGS) with 250X coverage and validated bioinformatics pipelines for accurate variant detection from EDTA blood samples.
Who should take this test?
Patients with unexplained genetic disorders, rare syndromes, or a family history of hereditary conditions may be recommended this test for comprehensive diagnosis.
What sample type is required?
An EDTA anticoagulated blood sample is required to provide high-quality DNA suitable for deep exome sequencing.
Why is high-depth clinical exome sequencing important?
Higher depth increases the sensitivity and accuracy of variant detection, ensuring even low-frequency mutations are identified for precise diagnosis.
How reliable are results from Metropolis Healthcare?
Metropolis Healthcare follows stringent quality control measures, validated NGS protocols, and expert interpretation to ensure accurate and reproducible results.
Is any preparation needed before the test?
No special preparation or fasting is required; patients should follow any instructions provided by their physician.
How soon are results available?
Turnaround time may vary due to comprehensive sequencing and analysis, but Metropolis Healthcare provides detailed reports promptly to support clinical decision-making.